Belvedere Trading LLC Kodiak Sciences Inc. Call Options Transaction History

Belvedere Trading LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 13, 2024	BUY	$1.4 - $3.24 $840 - $1,944	600 Added 3.55%	17,500 $53,000
Q3 2023 Oct 27, 2023	SELL	$1.8 - $7.49 $37,080 - $154,294	-20,600 Reduced 54.93%	16,900 $30,000
Q2 2023 Aug 08, 2023	BUY	$4.3 - $9.48 $161,250 - $355,500	37,500 New	37,500 $258,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $514M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.